Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...
Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback